Search

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. A Trial of Bexarotene in Multiple Sclerosis [CCMR One].

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. MS Society Press Release on the bexarotene trial. ... This new research is a major milestone in our plan to stop MS and we’re incredibly excited about the potential it’s shown for future studies.

23 Feb 2024: Nadira Fernando. Research Assistant. Nadira is a research assistant in the Brown Group. ... Jacky Porter. Clinical Research Manager. Jacky is clinical research manager for the Brown group.

23 Feb 2024: Site Search. Leading Cambridge neuroscientist appointed as Executive Chair of Medical Research Council. ... Department of Clinical Neurosciences. Featured news. Leading Cambridge neuroscientist appointed as Executive Chair of Medical Research Council.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Apathy could predict onset of dementia years before other symptoms. ... The research was largely funded by the Medical Research Council, Wellcome, and the National Institute for Health Research.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. CCMR2: A Trial of Metformin and Clemastine as Remyelinating Drugs in MS. ... Alasdair Coles, February 2023. This trial has been approved by a Research Ethics Committee:.

23 Feb 2024: This information will be used to form the basis of clinical trials, helping progress research towards a curative therapy for inherited optic neuropathies. ... Research aims:. The aim of this study is to understand how inherited optic neuropathies

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Long term follow-up from phase 3 alemtuzumab trials: 11-13 years after first dosing! ... Coles Ther Adv Neurol Disord 2023, Vol. 16: 1–16. Filed Under: News.

23 Feb 2024: The aim of this study therefore, is to assess the neurological progression of Ataxia-Telangiectasia and to select the best outcome measure for a future clinical trial, helping progress research towards ... Research aims:. The aim of this study is to

23 Feb 2024: SOUND Laboratory. Research projects. MRC Senior Fellowship Hearing Research (MR/S002537/1). Developing electrophysiological measures of brain activity to optimise cochlear implant (CI) outcomes. ... The BEARS project is funded by the National Institute

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. The role of Nicotinamide Riboside in mitochondrial biogenesis (NR).

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Promising molecule targets protein to offer hope for people with Parkinson’s. ... Its mission is to find a cure and improve life for everyone affected by Parkinson’s through cutting edge research,

23 Feb 2024: Quick Links. For staff. For alumni. For business. Colleges & departments. Libraries & facilities. Museums & collections. Email & phone search. Site Search. Site Search. Matthew Jennings. Horvath Laboratory. Matthew Jennings. Matt is a former PhD

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD). ... Research aims:. • To identify the genetic causes of neuromuscular and other neurogenetic conditions. •

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. The effects of oxygen in the context of mitochondrial dysfunction (Mitox). ... so. Research aims:. • To learn more about the role of oxygen in people with mitochondrial disease and in other conditions

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Drug incorporated into silicone coating reduces ‘foreign body reaction’ to implants. ... The research was supported by the Medical Research Council and Wellcome.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. 11C]PK11195 PET as a biomarker to diagnose and monitor natural history in mitochondrial disease.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. A prospective natural history study of patients with autosomal dominant optic atrophy (FALCON). ... Research aims. The aim of this commercially sponsored, natural history study is to evaluate the rate of

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Scientists detect dementia signs as early as nine years ahead of diagnosis. ... The research was funded by the Medical Research Council with support from the NIHR Cambridge Biomedical Research Centre.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. The Academy of Medical Sciences announces election of new Fellows 2021. ... Professor Adrian Liston. Senior Group Leader, Babraham Institute, Senior Research Fellow, Churchill College.